BEAM THERAPEUTICS INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+279.5% +$84M
$114M
R&D↓-2.1% -$2M
$99M
D&A↑+4.1% +$225K
$6M
Operating Income↓-19.1% -$20M
$-127M
EBITDA↑+4.1% +$225K
$6M
Other Income/Expense↑+43.2% +$4M
$14M
Pretax Income
$33M
Tax Provision
$0
Net Income
$33M
Operating Margin↓-561.2pts
-1307.6%
Net Margin
28.7%
Effective Tax Rate
0.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
7.0%
Operating Lease Cost↓-4.5% -$338K
$7M
Revenue YoY Variation↑+370.0pts
279.5%
Income YoY Variation↓-20.7pts
-19.1%
Revenue QoQ Variation↑+965.9pts
1076.6%
Income QoQ Variation↓-4.0pts
-5.5%